SFM
Sphera Funds Management Portfolio holdings
AUM
$382M
This Quarter Return
+14.5%
1 Year Return
+0.41%
3 Year Return
+99.29%
5 Year Return
+177.09%
10 Year Return
+575.73%
AUM
$462M
AUM Growth
+$462M
(+45%)
Cap. Flow
+$154M
Cap. Flow
% of AUM
33.42%
Top 10 Holdings %
Top 10 Hldgs %
38.37%
Holding
96
New
33
Increased
16
Reduced
11
Closed
16
Top Buys
| 1 |
Nice
NICE
|
$26.4M |
| 2 |
Teva Pharmaceuticals
TEVA
|
$18M |
| 3 |
Microsoft
MSFT
|
$15.7M |
| 4 |
Nutrien
NTR
|
$10.7M |
| 5 |
BridgeBio Pharma
BBIO
|
$9.32M |
Top Sells
| 1 |
ALBO
Albireo Pharma, Inc. Common Stock
ALBO
|
$10M |
| 2 |
Crinetics Pharmaceuticals
CRNX
|
$9.46M |
| 3 |
AstraZeneca
AZN
|
$7.98M |
| 4 |
CINC
CinCor Pharma, Inc. Common Stock
CINC
|
$6.51M |
| 5 |
FIVE9
FIVN
|
$6.45M |
Sector Composition
| 1 | Healthcare | 77.13% |
| 2 | Technology | 11.54% |
| 3 | Materials | 2.33% |
| 4 | Consumer Discretionary | 1.92% |
| 5 | Utilities | 1.65% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
|
SAGE
26
DELISTED
Sage Therapeutics
SAGE
| $6.5M | 1.09% | +155,000 | New | +$6.5M |
|
27
Merus
MRUS
$4.98B
| $6.2M | 1.04% | 336,993 +20,000 | +6% | +$368K |
|
28
Sarepta Therapeutics
SRPT
$1.78B
| $6.06M | 1.01% | +44,000 | New | +$6.06M |
|
29
Kezar Life Sciences
KZR
$28.9M
| $5.91M | 0.99% | 1,888,228 +583,045 | +45% | +$1.82M |
|
|
BLU
30
DELISTED
BELLUS Health Inc.
BLU
| $5.76M | 0.96% | 799,860 +310,000 | +63% | +$2.23M |
|
31
Pfizer
PFE
$141B
| $5.71M | 0.95% | +140,000 | New | +$5.71M |
|
|
ISEE
32
DELISTED
IVERIC bio, Inc. Common Stock
ISEE
| $5.63M | 0.94% | 231,591 +36,000 | +18% | +$876K |
|
33
Astria Therapeutics
ATXS
$349M
| $5.6M | 0.94% | 421,018 -48,322 | -10% | -$643K |
|
34
Novartis
NVS
$245B
| $5.52M | 0.92% | +60,000 | New | +$5.52M |
|
35
Immatics
IMTX
$619M
| $5.39M | 0.9% | 780,852 | – | – |
|
36
Mineralys Therapeutics
MLYS
$1.03B
| $5.31M | 0.89% | +339,000 | New | +$5.31M |
|
37
Arcellx
ACLX
$3.85B
| $5.16M | 0.86% | 167,488 -70,000 | -29% | -$2.16M |
|
38
Perion Network
PERI
$416M
| $5.15M | 0.86% | +130,000 | New | +$5.15M |
|
39
Kiniksa Pharmaceuticals
KNSA
$2.48B
| $4.85M | 0.81% | 450,283 +143,000 | +47% | +$1.54M |
|
|
FUSN
40
DELISTED
Fusion Pharmaceuticals Inc. Common Shares
FUSN
| $4.84M | 0.81% | +1,283,537 | New | +$4.84M |
|
41
Disc Medicine
IRON
$2.07B
| $4.66M | 0.78% | +220,013 | New | +$4.66M |
|
42
Madrigal Pharmaceuticals
MDGL
$9.76B
| $4.6M | 0.77% | +19,000 | New | +$4.6M |
|
|
GRCL
43
DELISTED
Gracell Biotechnologies Inc. American Depositary Shares
GRCL
| $4.39M | 0.73% | +2,360,580 | New | +$4.39M |
|
44
Travere Therapeutics
TVTX
$1.56B
| $4.22M | 0.7% | +187,500 | New | +$4.22M |
|
45
Rocket Pharmaceuticals
RCKT
$354M
| $4.04M | 0.68% | +236,000 | New | +$4.04M |
|
46
Palo Alto Networks
PANW
$127B
| $3.99M | 0.67% | +20,000 | New | +$3.99M |
|
47
Vaxcyte
PCVX
$4B
| $3.37M | 0.56% | +90,000 | New | +$3.37M |
|
48
Cogent Biosciences
COGT
$1.69B
| $3.24M | 0.54% | +300,000 | New | +$3.24M |
|
49
Cartesian Therapeutics
RNAC
$261M
| $3.23M | 0.54% | +2,325,000 | New | +$3.23M |
|
50
Mirum Pharmaceuticals
MIRM
$3.71B
| $2.63M | 0.44% | +109,336 | New | +$2.63M |
|